Joo-Yun Won

Joo-Yun Won

Auto-generated profile, based on publicly available information

Joo-Yun Won

AITRICS Corp, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2015 in Scientific Reports
Verified
Journal Article
Open access
SLSae-Won Lee
Sae-Won Lee
JWJoo-Yun Won
Joo-Yun Won
JYJimin Yang
Jimin Yang
JLJaewon Lee
Jaewon Lee
SKSu-Yeon Kim
Su-Yeon Kim
HKHyoSoo Kim
HyoSoo Kim
Skeletal muscle regeneration occurs continuously to repair muscle damage incurred during normal activity and in chronic disease or injury. Herein, we report that A-kinase anchoring protein 6 (AKAP6) is important for skeletal myoblast differentiation and muscle regeneration. Compared with unstimulated skeletal myoblasts that underwent proliferation, differentiated cells show significant stimulation of AKAP6 expression. AKAP6 knockdown with siRNA effectively halts the formation of myotubes and decreases the expression of the differentiation markers myogenin and myosin heavy chain. When shAKAP6-lentivirus is delivered to mice with cardiotoxin (CTX)-induced muscle injury, muscle regeneration is impaired compared with that of mice injected with control shMock-lentivirus. The motor functions of mice infected with shAKAP6-lentivirus (CTX+shAK6) are significantly worse than those of mice infected with shMock-lentivirus (CTX+shMock). Mechanistic analysis showed that AKAP6 promotes myogenin expression through myocyte enhancer factor 2A (MEF2A). Notably, myogenin increases AKAP6 expression as well. The results of chromatin immunoprecipitation and luciferase assays showed that myogenin binds to an E-box site on the AKAP6 promoter. Taken together, our findings demonstrate a novel interplay between AKAP6 and myogenin and we suggest that AKAP6 is an important regulator of myoblast differentiation, myotube formation and muscle regeneration.

20 June 2025 in BMJ Health & Care Informatics
Verified
Journal Article
Open access
PDF file
JKJi-hyun Kim
Ji-hyun Kim
Kyung Hyun LeeKyung Hyun Lee
Kyung Hyun Lee
KKKwang-il Kim
Kwang-il Kim
EHEun Yeong Ha
Eun Yeong Ha
IKIn-cheol Kim
In-cheol Kim
KLKi-Byung Lee
Ki-Byung Lee
Objective: The heterogeneous nature of sepsis renders determining its underlying causes difficult, which may delay diagnosis and intervention. VitalCare-SEPsis Score (VC-SEPS) is a deep learning-based algorithm that predicts sepsis and monitors patient conditions based on electronic medical record data. However, few studies have prospectively compared medical artificial intelligence software algorithms and traditional scoring systems to predict sepsis. This prospective observational study attempted to validate the predictive performance and risk stratification of VC-SEPS for early prediction of sepsis. Methods: In this prospective observational study, we collected electronic medical record data from 6,797 patients hospitalised at Keimyung University Dongsan Hospital, Daegu, South Korea. The final version of the analysed set included 6,455 patients, 325 of whom were diagnosed with sepsis. Results: The area under the receiver operating characteristic curve of VC-SEPS was 0.880, indicating its superiority over traditional scoring systems. The algorithm performance showed a consistent trend within 24 hours. On patients’ initial admission, the VC-SEPS was associated with the risk of developing sepsis, and the score accurately predicted sepsis by an average of 68.05 min compared with diagnosis time by an operational definition of sepsis. Discussion: VC-SEPS could assist medical staff with early diagnosis and intervention in clinical practice by providing a sepsis risk score. Prompt recognition assisting recognition can significantly help shorten the time between recognition and intervention in clinical decision-making processes. Conclusion: This study suggests that using a clinical decision support system can help improve hospital workflows as well as the quality of medical care.

20 February 2024 in Archives of Plastic Surgery
Verified
Journal Article
Open access
PDF file
MSMan Koon Suh
Man Koon Suh
JWJoo-Yun Won
Joo-Yun Won
JBJung-Hwan Baek
Jung-Hwan Baek
Most Asians have a nose with a short columella and a low dorsum; augmentation rhinoplasty using implants is commonly performed in Asian countries to achieve a taller and more well-defined nasal dorsum. However, the current knowledge is insufficient to fully understand the various subjective desires of patients, reflect on them during surgery, or to objectively analyze the results after surgery. Advances in digital imaging technologies, such as 3D printing and 3D scanning, have transformed the medical system from hospital-centric to patient-centric throughout the medical field. In this study, we applied these techniques to rhinoplasty. First, we used virtual 3D plastic surgery software to enable surgical planning through objectified numerical calculations based on the visualized data of the patient's medical images rather than simple virtual plastic surgery. Second, the customized nasal implant was manufactured by reflecting the patient's anatomical shape and virtual 3D plastic surgery data. Taken together, we describe the surgical results of applying these rhinoplasty solutions in four patients. Our experience indicates that high fidelity and patient satisfaction can be achieved by applying these techniques.

31 May 2025 in Acute and Critical Care
Verified
Journal Article
Open access
TSTaeyong Sim
Taeyong Sim
ECEun Young Cho
Eun Young Cho
JKJi-hyun Kim
Ji-hyun Kim
Kyung Hyun LeeKyung Hyun Lee
Kyung Hyun Lee
KKKwang-il Kim
Kwang-il Kim
KLKi-Byung Lee
Ki-Byung Lee
Background: Acute deterioration of patients in general wards often leads to major adverse events (MAEs), including unplanned intensive care unit transfers, cardiac arrest, or death. Traditional early warning scores (EWSs) have shown limited predictive accuracy, with frequent false positives. We conducted a prospective observational external validation study of an artificial intelligence (AI)-based EWS, the VitalCare - Major Adverse Event Score (VC-MAES), at a tertiary medical center in the Republic of Korea. Methods: Adult patients from general wards, including internal medicine (IM) and obstetrics and gynecology (OBGYN)—the latter were rarely investigated in prior AI-based EWS studies—were included. The VC-MAES predictions were compared with National Early Warning Score (NEWS) and Modified Early Warning Score (MEWS) predictions using the area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), and logistic regression for baseline EWS values. False-positives per true positive (FPpTP) were assessed based on the power threshold. Results: Of 6,039 encounters, 217 (3.6%) had MAEs (IM: 9.5%, OBGYN: 0.26%). Six hours prior to MAEs, the VC-MAES achieved an AUROC of 0.918 and an AUPRC of 0.352, including the OBGYN subgroup (AUROC, 0.964; AUPRC, 0.388), outperforming the NEWS (0.797 and 0.124) and MEWS (0.722 and 0.079). The FPpTP was reduced by up to 71%. Baseline VC-MAES was strongly associated with MAEs (P<0.001). Conclusions: The VC-MAES significantly outperformed traditional EWSs in predicting adverse events in general ward patients. The robust performance and lower FPpTP suggest that broader adoption of the VC-MAES may improve clinical efficiency and resource allocation in general wards.

22 August 2025 in JMIR Medical Informatics
Verified
Journal Article
Open access
JKJi-hyun Kim
Ji-hyun Kim
ECEun Young Cho
Eun Young Cho
YCYuhyun Choi
Yuhyun Choi
JWJoo-Yun Won
Joo-Yun Won
SCSe Hee Cheon
Se Hee Cheon
TSTaeyong Sim
Taeyong Sim
Background: In hospitals, Code Blue is an emergency that refers to a patient requiring immediate resuscitation. Over 85% of patients with cardiopulmonary arrest exhibit abnormal vital sign trends prior to the event. Continuous monitoring and accurate interpretation of clinical data through artificial intelligence (AI) models can contribute to preventing critical events. Objective: This study aims to evaluate changes in clinical outcomes following the use of VitalCare (Major Adverse Event Score and Mortality Score), which is an AI-based early warning system, and to validate the performance of the algorithm. Methods: A retrospective analysis was conducted by extracting electronic health record data, using a total of 30,785 inpatient cases from general wards and intensive care units. A comparative analysis was performed by setting a 3-month period before and after the system implementation. For clinical evaluation, we measured the incidence rates of Code Blue and adverse events, the proportion of prolonged hospitalization, and the frequency of early interventions. The area under the receiver operating characteristic curve (AUROC) was calculated to assess the performance of the algorithm. Results: This study demonstrated that, following the implementation of VitalCare, there was a 24.97% reduction in major events such as Code Blue (P=.004) and the proportion of prolonged hospitalization in general wards (P<.05), along with a significant increase in the rate of early interventions. The model performance exhibited superior outcomes compared with traditional scoring systems, with a Major Adverse Event Score AUROC of 0.865 (95% CI 0.857‐0.873) and Mortality Score AUROC of 0.937 (95% CI 0.931‐0.944). Conclusions: A well-developed AI-based model that provides high predictive power can contribute to the prevention of major in-hospital events by providing early predictive information to clinicians. Additionally, it plays a crucial role in effectively addressing unmet needs and challenges in terms of human resources and practical procedures.

24 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
YKYeji Kim
Yeji Kim
SHSangchul Hahn
Sangchul Hahn
KKKwang-il Kim
Kwang-il Kim
EYEunho Yang
Eunho Yang
JKJi-hyun Kim
Ji-hyun Kim
TSTaeyong Sim
Taeyong Sim
The timely detection of ward deterioration—including unplanned intensive care unit (ICU) transfer, cardiac arrest, death, and sepsis—remains an unmet need. Although rule-based early warning scores and newer machine-learning models have been introduced, their clinical adoption is limited owing to challenges such as low predictive performance, excessive false alarms, and lack of generalizability. This study aimed to develop two deep-learning models for patients in general wards using a bidirectional long short-term memory neural network architecture: (i) the VitalCare-Major Adverse Event Score (VC-MAES), which predicts clinical deterioration events (CDEs)— unplanned ICU transfer, cardiac arrest, or in-hospital death—within 6 h and (ii) the VitalCare-SEPsis Score (VC-SEPS), which predicts sepsis onset within 4 h. Additionally, we sought to externally validate the performance of the models in an independent cohort. This study was conducted in two sequential phases. First, the VC-MAES and VC-SEPS models were developed using a large retrospective cohort from Yonsei Severance Hospital, Seoul, Republic of Korea. Second, external validation was performed in a single-center cohort at National Health Insurance Service Ilsan Hospital (NHIS Ilsan Hospital), Ilsan, Republic of Korea. Both algorithms incorporated patient age, vital signs, laboratory results, and the Glasgow Coma Scale scores. VC-MAES performance was compared with the Modified Early Warning Score (MEWS) and National Early Warning Score (NEWS), whereas VC-SEPS performance was compared with the Sequential Organ Failure Assessment (SOFA), quick SOFA (qSOFA), and NEWS, using the area under the receiver operating characteristic curve (AUROC) as the primary performance metric. The derivation cohort comprised 357,009 adult general-ward admissions at Yonsei Severance Hospital (2013–2017), and the external validation cohort included 22,073 admissions at NHIS Ilsan Hospital (2017). In the external validation cohort, the VC-MAES predicted CDEs within 6 h with an AUROC of 0.918 (95% confidence interval [CI], 0.909–0.927), outperforming the MEWS (0.834; 95% CI, 0.820–0.849) and NEWS (0.883; 95% CI, 0.869– 0.896). VC-SEPS predicted sepsis onset within 4 h, with an AUROC of 0.941 (95% CI, 0.934–0.947), surpassing the SOFA (0.559; 95% CI, 0.546–0.571), qSOFA (0.687; 95% CI, 0.671–0.704), and NEWS (0.767; 95% CI, 0.748–0.785). Both models maintained AUROC values above 0.86 across all age and sex categories. The VC-MAES and VC-SEPS outperformed conventional early warning scores in predicting clinical deterioration events and sepsis. These models can enable earlier and more precise interventions, enhancing patient care and optimizing resource use, ultimately leading to better patient outcomes without overwhelming healthcare providers.